Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP
- PMID: 19804476
- DOI: 10.1111/j.1600-0404.2009.01196.x
Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP
Abstract
Objective: To investigate the predictive value of early serum levels of S100B and glial fibrillary acidic protein (GFAP) in traumatic brain injury.
Methods: Sixty patients admitted within 24 h of trauma were included. Neurological status on admission (Glasgow Coma Scale), initial cranial computed tomography (CCT) studies (Marshall Computed Tomographic Classification), and outcome after 6 months (Glasgow Outcome Scale) were evaluated. S100B and GFAP levels were determined on admission and 24 h after trauma.
Results: Blood levels of S100B and GFAP were elevated following head trauma and quantitatively reflected the severity of trauma. S100B levels after 24 h and on admission were of higher predictive value than CCT findings or clinical examination. GFAP, but not S100B levels rapidly declined after trauma.
Conclusions: Blood levels of S100B and GFAP indicate the severity of brain damage and are correlated with neurological prognosis after trauma. Both methods can yield additional prognostic information if combined with clinical and CCT findings.
Similar articles
-
GFAP and S100B in the acute phase of mild traumatic brain injury.Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18. Neurology. 2012. PMID: 22517109
-
S100B is not a reliable prognostic index in paediatric TBI.Pediatr Neurosurg. 2007;43(4):258-64. doi: 10.1159/000103304. Pediatr Neurosurg. 2007. PMID: 17627141
-
Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.Acta Neurochir (Wien). 2008 Mar;150(3):221-7; discussion 227. doi: 10.1007/s00701-007-1489-2. Epub 2008 Jan 14. Acta Neurochir (Wien). 2008. PMID: 18193148
-
The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications.Prog Brain Res. 2007;161:317-25. doi: 10.1016/S0079-6123(06)61022-4. Prog Brain Res. 2007. PMID: 17618987 Review.
-
[Interest of S100B protein blood level determination in severe or moderate head injury].Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):145-50. doi: 10.1684/abc.2013.0812. Ann Biol Clin (Paris). 2013. PMID: 23587577 Review. French.
Cited by
-
A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury.Mol Diagn Ther. 2012 Apr 1;16(2):79-92. doi: 10.2165/11631580-000000000-00000. Mol Diagn Ther. 2012. PMID: 22497529 Review.
-
The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity.Cardiovasc Psychiatry Neurol. 2010;2010:801295. doi: 10.1155/2010/801295. Epub 2010 Jul 8. Cardiovasc Psychiatry Neurol. 2010. PMID: 20671945 Free PMC article.
-
Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions.Int J Mol Sci. 2013 Jan 17;14(1):1890-917. doi: 10.3390/ijms14011890. Int J Mol Sci. 2013. PMID: 23344061 Free PMC article. Review.
-
Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans.Neurology. 2020 Sep 1;95(9):e1126-e1133. doi: 10.1212/WNL.0000000000010087. Epub 2020 Jun 22. Neurology. 2020. PMID: 32571850 Free PMC article.
-
Serum S100B Protein as an Outcome Prediction Tool in Emergency Department Patients with Traumatic Brain Injury.Turk J Emerg Med. 2016 Mar 2;14(4):147-52. doi: 10.5505/1304.7361.2014.74317. eCollection 2014 Dec. Turk J Emerg Med. 2016. PMID: 27437512 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous